$9.6 million grant fuels UCI malaria control research in Africa
Irvine, Calif., April 27, 2017 — A University of California, Irvine study on the impact of environmental changes on malaria in sub-Saharan Africa has been awarded up to $9.6 million over seven years from the National Institute of Allergy & Infectious Diseases, a part of the National Institutes of Health.
The funding establishes UCI as one of the International Centers of Excellence for Malaria Research, which will engage in projects in Africa, Asia and Latin America. Guiyun Yan, professor of public health, leads the UCI project.
"Knowledge gained from this ICEMR will be important to malaria control, not only for the two countries studied – Ethiopia and Kenya – but also for other regions of Africa," Yan said.
He added that the overarching goal of UCI's ICEMR is to assess the effect of human-induced environmental modifications – such as dam construction, irrigation and shifting agricultural practices – on the epidemiology and transmission of malaria. Because of food insufficiencies, major investments have been made in water resource development in highly populated Kenya and Ethiopia.
An international partnership
To address the major knowledge gaps and challenges in malaria control and elimination in the face of drastic environmental changes in sub-Saharan Africa, the UCI ICEMR is establishing a consortium with researchers from the U.S., Australia, Kenya and Ethiopia to explore scientific questions important to global anti-malaria efforts, especially in Greater Horn of Africa countries.
The ICEMR has three projects, each with multiple specific objectives. One will gauge the impact of environmental modifications related to water resource development on malaria epidemiology at the molecular, individual, field and population levels. A second will examine the ramifications of environmental changes on vector ecology and transmission, the outcomes of which will inform innovative integrated vector control approaches. The third aim is to determine the effect of environmental modifications on malaria pathogenesis and immunity.
The malaria challenge
Despite significant progress in reducing malaria incidence and mortality, the World Health Organization estimates that 212 million new cases of malaria and 429,000 malaria deaths occurred in 2015, mostly in Africa. Although numerous potential vaccines to prevent malaria are in the works, none have been approved for widespread use. Effective malaria treatments are available, but some have severe side effects, may be difficult to procure in remote regions, and are losing their efficacy in places where malaria-causing parasites have developed resistance. Mosquito control, which relies largely on bed nets and insecticides, is still a front-line defense where malaria is endemic, but changes in mosquito behavior and insecticide resistance are increasing concerns.
For more about the ICEMR network, see https://www.niaid.nih.gov/research/excellence-malaria-research. The UCI funding comes under grant 1U19AI129326-01.
About the University of California, Irvine: Founded in 1965, UCI is the youngest member of the prestigious Association of American Universities. The campus has produced three Nobel laureates and is known for its academic achievement, premier research, innovation and anteater mascot. Led by Chancellor Howard Gillman, UCI has more than 30,000 students and offers 192 degree programs. It's located in one of the world's safest and most economically vibrant communities and is Orange County's second-largest employer, contributing $5 billion annually to the local economy. For more on UCI, visit http://www.uci.edu.
Media access: Radio programs/stations may, for a fee, use an on-campus ISDN line to interview UCI faculty and experts, subject to availability and university approval. For more UCI news, visit news.uci.edu. Additional resources for journalists may be found at communications.uci.edu/for-journalists.